Lysoflam Tablet is a combination analgesic and anti-inflammatory medication containing Diclofenac 50 mg, Paracetamol 325 mg, and Trypsin Chymotrypsin 50,000 AU. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), exerts potent anti-inflammatory, analgesic, and antipyretic effects by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol complements this action by providing effective analgesia and antipyresis through central inhibition of prostaglandin synthesis without significant anti-inflammatory activity. Trypsin Chymotrypsin, a proteolytic enzyme combination, facilitates the reduction of inflammation and edema by promoting the breakdown of inflammatory mediators and fibrin deposits, enhancing tissue repair and recovery. Lysoflam is indicated for the management of acute musculoskeletal pain, postoperative inflammation, soft tissue injuries, and inflammatory conditions such as arthritis and tendinitis. The synergistic action of these components provides rapid relief from pain and inflammation while supporting tissue healing. It is recommended to use Lysoflam under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, active gastrointestinal ulcers, or bleeding disorders. Caution is advised in patients with hepatic or renal impairment. Adverse effects may include gastrointestinal discomfort, allergic reactions, or mild enzyme-related side effects.